$0.72 dividends are within arm’s reach for Allergan plc (NYSE:AGN) shareholders.

May 16, 2018 - By Robert Sims

Allergan plc (NYSE:AGN) LogoInvestors sentiment increased to 1.25 in Q4 2017. Its up 0.92, from 0.33 in 2017Q3. It improved, as 2 investors sold Allergan plc shares while 2 reduced holdings. 1 funds opened positions while 4 raised stakes. 44,210 shares or 18.56% less from 54,287 shares in 2017Q3 were reported.
Eqis Cap Management holds 0.09% or 10,789 shares in its portfolio. Cubic Asset Mngmt Ltd Liability Company holds 0.11% or 2,321 shares in its portfolio. American & Mgmt Com reported 33 shares. Mitchell Mcleod Pugh & Williams, Alabama-based fund reported 3,965 shares. Gemmer Asset Management Limited Liability Corporation owns 214 shares. Callahan Advisors Limited Liability owns 4,500 shares or 0.15% of their US portfolio. Grassi Invest Mngmt reported 7,435 shares or 0.2% of all its holdings. Frontier Invest Management stated it has 14,953 shares or 0.2% of all its holdings.

Allergan plc (NYSE:AGN) is expected to pay $0.72 on Jun 15, 2018. Shareholders owning the stock before May 17, 2018 will be eligible to receive the payout. Based on Allergan plc’s current price of $152.81, the dividend is 0.47 %. This dividend’s record date is May 18, 2018 and the announcement date is May 3, 2018. The stock decreased 1.00% or $1.55 during the last trading session, reaching $152.81. About 2.41M shares traded. Allergan plc (NYSE:AGN) has declined 33.03% since May 16, 2017 and is downtrending. It has underperformed by 44.58% the S&P500.

Allergan plc, a specialty pharmaceutical company, develops, makes, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. The company has market cap of $51.81 billion. It operates through US Specialized Therapeutics, US General Medicine, and International divisions. It currently has negative earnings. The firm offers a portfolio of products that provide treatment for the central nervous system, gastroenterology, women's health and urology, ophthalmology, neurosciences, medical aesthetics, dermatology, plastic surgery, liver disease, inflammation, metabolic syndromes, and fibrosis, as well as Alzheimer's disease.

Allergan plc (NYSE:AGN) Ratings Coverage

Among 18 analysts covering Allergan PLC (NYSE:AGN), 12 have Buy rating, 0 Sell and 6 Hold. Therefore 67% are positive. Allergan PLC has $25500 highest and $171.0 lowest target. $208.73’s average target is 36.59% above currents $152.81 stock price. Allergan PLC had 30 analyst reports since November 27, 2017 according to SRatingsIntel. On Wednesday, February 7 the stock rating was maintained by Credit Suisse with “Outperform”. The stock of Allergan plc (NYSE:AGN) earned “Buy” rating by Credit Suisse on Thursday, March 1. Cowen & Co maintained it with “Buy” rating and $25500 target in Monday, April 16 report. The rating was maintained by Cantor Fitzgerald on Tuesday, May 1 with “Neutral”. On Wednesday, January 3 the stock rating was maintained by Leerink Swann with “Buy”. The stock has “Buy” rating by RBC Capital Markets on Thursday, January 4. The stock of Allergan plc (NYSE:AGN) earned “Buy” rating by Bank of America on Tuesday, May 1. Susquehanna maintained the stock with “Hold” rating in Wednesday, January 17 report. The stock of Allergan plc (NYSE:AGN) has “Buy” rating given on Tuesday, December 19 by Credit Suisse. Citigroup maintained Allergan plc (NYSE:AGN) on Tuesday, April 24 with “Buy” rating.

More notable recent Allergan plc (NYSE:AGN) news were published by: Seekingalpha.com which released: “Allergan: Too Much Focus On The Bad” on May 02, 2018, also Seekingalpha.com with their article: “Key events next week – healthcare” published on May 11, 2018, Seekingalpha.com published: “Allergan: Sell That Volatility” on May 08, 2018. More interesting news about Allergan plc (NYSE:AGN) were released by: Streetinsider.com and their article: “JANA Shows New Stakes in Apple (AAPL), Boston Scientific (BSX), Dropbox (DBX), iQIYI (IQ) (more..) -13F” published on May 15, 2018 as well as Streetinsider.com‘s news article titled: “Glenview Capital Enters AmerisourceBergen (ABC), Express Scripts (ESRX), T-Mobile (TMUS) (more…) -13F” with publication date: May 15, 2018.

Allergan plc (NYSE:AGN) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: